Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288119![]() (Production of 7′-(3-chloro-2-fluorobenzylcar...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.700 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288127![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.700 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288106![]() (Production of Monosodium 7′-(3-chloro-2-fluo...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288126![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288115![]() (Production of N-(3-chloro-2-fluorobenzyl)-9′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288131![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288113![]() (Production of N-(3-chloro-2-fluorobenzyl)-9′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288125![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288122![]() (US10087178, Example 40) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288124![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288128![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288112![]() (US10087178, Example 30) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.10 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288132![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.10 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288129![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288121![]() (Production of (E)-4-[7′-(3-chloro-2-fluorobe...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288109![]() (Production of N-(3-chloro-2-fluorobenzyl)-9′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288105![]() (Production of N-(3-chloro-2-fluorobenzyl)-9′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.60 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288130![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.90 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288172![]() ((1S,2S)-N-(2,4- difluorobenzyl)-2'-ethyl-9'- hydro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.90 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288108![]() (Production of N-(3-chloro-2-fluorobenzyl)-9′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.90 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288113![]() (Production of N-(3-chloro-2-fluorobenzyl)-9′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.90 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288024![]() (US10087178, Example 6) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288107![]() (Production of Monopotassium 7′-(3-chloro-2-f...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.10 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288110![]() (Production of Monosodium 7′-(3-chloro-2-fluo...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.20 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288173![]() ((1S,2S)-N-(2,4- difluorobenzyl)-9'-hydroxy- 2'-iso...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.20 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288080![]() (N-(3-chloro-2-fluorobenzyl)- 9'-hydroxy-trans-3- i...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.30 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288091![]() (N-(2,4-difluorobenzyl)-cis- 3-ethoxy-9'-hydroxy-2'...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288111![]() (Production of Monopotassium 7′-(3-chloro-2-f...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288037![]() (US10087178, Example 18) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.60 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288118![]() (Production of Monopotassium 7′-(3-chloro-2-f...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.60 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288123![]() (7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288171![]() ((1S,2S)-N-(2,4- difluorobenzyl)-2'-ethyl-9'- hydro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288022![]() (US10087178, Example 4) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.90 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288023![]() (US10087178, Example 5) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.90 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288019![]() (US10087178, Example 1) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.10 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288156![]() ((1R,2R)-N-(3-chloro-2- fluorobenzyl)-9'-hydroxy-2-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288021![]() (US10087178, Example 3) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288116![]() (Production of N-(3-chloro-2-fluorobenzyl)-2′...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288164![]() ((1S,2S)-N7'-(3-chloro-2- fluorobenzyl)-2'-cyclopro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.30 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288165![]() ((1R,2R)-N7'-(3-chloro-2- fluorobenzyl)-2'-cyclopro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.30 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288066![]() (N-(3-chloro-2-fluorobenzyl)- trans-3,9'-dihydroxy-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288036![]() (US10087178, Example 17) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288178![]() ((1R,2R)-N-(3-chloro-2- fluorobenzyl)-2'-ethyl-9'- ...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288145![]() ((1S,2S)-N7'-(3-chloro-2- fluorobenzyl)-9'-hydroxy-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.40 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288152![]() ((1R,2R)-N-(3-chloro-2- fluorobenzyl)-2'-ethyl-9'- ...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288079![]() (N-(3-chloro-2-fluorobenzyl)- cis-3-(ethoxymethyl)-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288081![]() (N-(3-chloro-2-fluorobenzyl)- 9'-hydroxy-cis-3-isop...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288087![]() (N-(3-chloro-2-fluorobenzyl)- 2'-ethyl-9'-hydroxy-c...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288092![]() (N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-tr...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
HIV-1 Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288060![]() (N-(2,4-difluorobenzyl)-2'- ethyl-9'-hydroxy-cis-3-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.5 | n/a | n/a | n/a | 25 |
Japan Tobacco Inc US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 163 total ) | Next | Last >> |